Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Arginine glutamate (substance) |
Is a |
False |
Amino acid injection |
Inferred relationship |
Some |
|
Cysteine preparation |
Is a |
False |
Amino acid injection |
Inferred relationship |
Some |
|
Amino acids peritoneal dialysis solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
7 % aminosyreopløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
8,5 % aminosyreopløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
10 % aminosyreopløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
5,4 % aminosyreopløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
15 % aminosyreopløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
Aminosyrer 20 % injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
Aminosyrer 6 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
Aminosyrer 8 % injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
5 % aminosyreopløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
8 % aminosyreopløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
Aminosyre, injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
Aminosyrer 10 % injektionsvæske, opløsning, flaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
Aminosyrer 6,9 % injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
Aminosyrer 8,5 % injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|
11,4 % aminosyreopløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amino acid injection |
Inferred relationship |
Some |
|